CONTEXT: Commercial announcement of a significant acquisition in the RWD space | Is this the biggest deal we will see this year or is there more to come? IMPACT: Medium Continue Reading
CONTEXT: Report of findings from a RWE expanded access study in NSCLC patients presented at the European Lung Cancer Congress. The initial findings showed a difference in outcomes for those Continue Reading
CONTEXT: Just to show that RWR is not all cutting edge biotech, this real-world study report demonstrates both a cost saving and better treatment satisfaction for wound care. IMPACT: Medium Continue Reading
CONTEXT: This is a great article on just how valuable RWR / RWE is becoming for regulators worldwide as they will invariably follow the FDA’s lead | Be honest if the Continue Reading
CONTEXT: Summary article on the continuing interest and need for RWR, fuelled by the COVID pandemic. IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – 10]: 5 1. Continue Reading
CONTEXT: FDA publishing an action plan on AI in SAAMDs. China already ahead of the game in terms of how they have already enacted guidance on AI in SAAMDs, but Continue Reading
CONTEXT: Mostly advert for cox platform, but interesting EMR based use of RWD – stretching the definition of a decentralised study though, US Only IMPACT: RWE insights based on de-identified Continue Reading
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.
IMPACT: Preliminary RWE on effectiveness of single dose of Pfizer vaccine; 1st dose of the Pfizer vaccine seen to curb infection rates by 50% within 14 days; data from 800,000 Continue Reading
